Big Pharma invested in MAGA policy planning, targeting the repeal of Biden's Medicare drug price negotiation program.

Big Pharma has invested heavily in organizations planning the MAGA policy agenda for a potential new Trump administration, specifically focusing on a policy that would repeal the Biden administration's program allowing Medicare to negotiate lower drug prices. The pharmaceutical industry has contributed significantly to the far-right Project 2025, an agenda meant to serve as direction for early actions in a Trump presidency. In response to Congress barring Medicare from negotiating prescription drug prices, which is a primary reason for higher drug prices in the U.S. compared to other countries, Democrats enacted legislation in 2022 to create a price negotiation pilot program.

January 25, 2024
10 Articles